COVID-19: Oxford vaccine to be tested on children as young as six in world-first trial originalfm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from originalfm.com Daily Mail and Mail on Sunday newspapers.
Britain to test AstraZeneca COVID-19 vaccine in children
By (0)
A father greets his daughter after arriving in a Eurostar train from Paris, in St Pancras station in London. File Photo by Facundo Arrizabalaga/EPA-EFE
Feb. 13 (UPI) Britain plan to test the the Oxford/AstraZeneca COVID-19 vaccine in children as young as 6 this month, the university announced Saturday.
Researchers will test the efficacy of the vaccine through a clinical trial of 300 volunteers, ages 6 to 17, to determine if it produces a strong immune response, The Guardian reported. Up to 240 children will receive the vaccine in the trial this month and others will receive a control meningitis shot.
AstraZeneca COVID-19 vaccine to be tested on children, teens
Updated Feb 13, 2021;
The University of Oxford announced Saturday that it’s launching trials for its COVID-19 vaccine involving children and teenagers for the first time.
The study seeks to assess effectiveness and safety of its coronavirus shot which was developed in partnership with the British–Swedish pharmaceutical company AstraZeneca in younger people.
Around 300 volunteers, between the ages of 6 and 17, are set to participate in the study, which is scheduled to begin later this month.
The two-dose Oxford vaccine has some clear advantages over its competitors that makes it easier to use.
The Oxford University COVID-19 vaccine is to begin testing its efficacy in children aged six to 17. It will be the first trial in children so young. Children